Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and dexamethasone for prevention of postoperative nausea and vomiting after radical mastectomy
ChiCTR2000032943Phase 4Suspended
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and dexamethasone in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoints: 5-hydroxytryptamine, prostaglandins and 3 more. Started Feb 2020; status: suspended.
02
Drugs
dexmedetomidinedexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2000032943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032943.